Disrupting CD22-cis-ligand interactions ameliorates type 1 diabetes and graft rejection by expanding regulatory B cells
- Journal:
- PLOS Biology
- Published:
- DOI:
- 10.1371/journal.pbio.3003681
- Affiliations:
- 9
- Authors:
- 10
| Institutions | Authors | Share |
|---|---|---|
| Institute of Science Tokyo (Science Tokyo), Japan | 0.47 | |
| Nihon University, Japan | 0.23 | |
| Tokyo University of Science (TUS), Japan | 0.10 | |
| Fujita Health University, Japan | 0.10 | |
| Keio University, Japan | 0.05 | |
| RIKEN Center for Integrative Medical Sciences (IMS), Japan | 0.05 |